tirzepatide cardiovascular outcomes trial results july 2025 US Population Eligibility and Estimated Impact of Treatment on Obesity Prevalence and Disease Events | Cardiovascular Drugs and Therapy Effects of tirzepatide on circulatory

In clinical trials, 7%--13% of people taking Wegovy experienced burping

Effectiveness: Oral vs Injectable Options Clinical trial data clearly shows injectable GLP-1 medications produce substantially greater weight loss than oral options

Some users even report increased energy as reduced caloric intake paradoxically frees up metabolic resources that were previously devoted to processing excess food

[DOI] [PubMed] [Google Scholar] 111.Tang S.T., Tang H.Q., Su H., Wang Y., Zhou Q., Zhang Q., Wang Y., Zhu H.Q

The sensation of persistent fullness or early satietywhile therapeutically beneficial for weight losscan become uncomfortable and contribute to decreased appetite beyond what feels tolerable